Bunout D, Garrido A, Suazo M, Kauffman R, Venegas P, de la Maza P, Petermann M & Hirsch S (2000) Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients. Nutrition 16, 107–110.
Carr AC & Frei B (1999) Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. American Journal of Clinical Nutrition 69, 1086–1107.
Correa P (1983) The precancerous process. Cancer Survey 2, 437–450.
Correa P (1988) A human model of gastric carcinogenesis. Cancer Research 48, 3554–3565.
Correa P (1992) Human gastric carcinogenesis: a multistep and multifactoral process. Cancer Research 52, 6735–6740.
Davies GR, Simmonds NJ, Stevens TRJ, Grandison A, Blake DR & Rampton DS (1992) Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 33, 1467–1472.
Dixon MF, O'Connor H, Axon ATR, King RFJG & Johnston D (1986) Reflux gastritis: distinct histopathological entity? Journal of Clinical Pathology 39, 524–530.
Dizdaroglu M (1993) Chemistry of free radical damage to DNA. In DNA and Free Radicals pp. 19–39 [Halliwell B and Arunoma OI, editors]. Chichester: Ellis Horwood.
Drake IM, Davies MJ, Mapstone NP, Dixon MF, Schorah CJ, White KLM, Chalmers DM & Axon ATR (1996) Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis 17, 559–562.
Drake IM, Mapstone NP, Schorah CJ, White KLM, Chalmers DM, Dixon MF & Axon ATR (1998) Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: Relation to gastric mucosal ascorbic acid concentrations and the effect of H. pylori eradication. Gut 42, 768–771.
Drake IM, Warland D, Carswell N, Schorah CJ, Mapstone N, Axon ATR, Chalmers DM, Dixon MF & White KLM (1995) Reactive oxygen species (ROS) activity and damage in Helicobacter pylori associated gastritis: effect of eradication therapy. Gut 35, Suppl., 10.
Everett SM, Drake IM, White KLM, Mapstone NP, Chalmers DM, Schorah CJ & Axon ATR (2002) Antioxidant vitamin supplements do not reduce the reactive oxygen species activity in Helicobacter pylori gastritis in the short term. British Journal of Nutrition 87, 3–11.
Everett SM, Singh R, Leuratti C, White KLM, Neville P, Greenwood D, Marnett LJ, Schorah CJ, Forman D, Shuker D & Axon ATR (2001) Levels of malondialdehyde-deoxyganosine in the gastric mucosa – relationship with lipid peroxidation, ascorbic acid and Helicobacter pylori Cancer Epidemiology, Biomarkers and prevention 10, 369–376.
Everett SM, White K, Calvert R, Drake IM, Skinner C, Miller D, Schorah CJ & Axon ATR (1996) The measurement of DNA single strand breaks, using the 'COMET' assay, in Helicobacter pylori associated gastritis. Gut 38, Suppl., A2.
Everett SM, White KLM, Schorah CJ, Calvert RJ, Skinner C, Miller D & Axon ATR (2000) In vivo DNA damage in gastric epithelial cells. Mutation Research 468, 73–85.
Fang JL, Vaca CE, Valstra LM & Mutamen M (1996) Determination of DNA adducts of malondialdehyde in humans; effects of dietary fatty acid composition. Carcinogenesis 17, 1035–1040.
Guyton KZ & Kensler TN (1993) Oxidative mechanisms in carcinogenesis. British Medical Bulletin 49, 523–544.
Halliwell B (1994) Free radicals, antioxidants and human disease. Lancet 344, 721–724.
Hayat M, Everett SM, White KLM, Drake IM & O'Mahony S (1998) Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa in lymphocytic gastritis. Gastroenterology 114, A146.
Kyrtopoulos SA (1989) N-nitroso compound formation in human gastric juice. Cancer Surveys 8, 423–442.
Lunec J (1990) Free radicals: their involvement in disease processes. Annals of Clinical Biochemistry 27, 173–182.
Monget AL, Richard MJ, Cournot MP, Arnaud J, Galan P, Preziosi P, Herbeth B, Favier A & Hereberg S (1996) Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min. Vit. Axon Network. European Journal of Clinical Nutrition 50, 443–449.
Mowat C, Carswell A, Wirz A & McColl KEL (1999) Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology 116, 813–822.
Mowat C, Williams C, Gillen D, Hossack M, Gilmour D, Carswell A, Wirz A, Preston T & McColl KEL (2000) Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology 119, 339–347.
O'Connor HJ, Schorah CJ, Habibzedah N, Axon ATR & Cockel R (1989) Vitamin C in the human stomach; relation to gastric pH, gastroduodenal disease and possible sources. Gut 30, 436–442.
Sanderson MJ, White KLM, Drake IM & Schorah CJ (1997) Vitamin E and carotenoids in gastric biopsies: the relation to plasma concentrations in patients with and without Helicobacter pylori gastritis. American Journal of Clinical Nutrition 65, 101–106.
Schorah CJ (1990) Gastric juice ascorbic acid; Effects of disease, hypochlorhydria and stimulation of gastric secretion. Proceedings of the Nutrition Society 49, 31A.
Schorah CJ (1995) Micronutrients, antioxidants and risk of cancer. Bibliotheca Nutritio Dieta 52, 92–107.
Schorah CJ (1997) Ascorbic acid metabolism in the human stomach. Acta Gastro-Enterologica Belgica 60, 217–219.
Schorah CJ, Sobala GM, Sanderson M, Collis N & Primrose JN (1991) Gastric juice ascorbic acid: effect of disease and implications for gastric carcinogenesis. American Journal of Clinical Nutrition 53, 287s–293s.
Singh NP, McCoy MT, Tire RR & Schnieder EL (1988) A simple technique for quantification of low levels of DNA damage in individual cells. Experimental Cell Research 5, 184–191.
Sobala GM, Pignatelli B, Schorah CJ, Bartsh H, Sanderson M, Dixon MF, Shires S, King RFJG & Axon ATR (1991) Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 12, 193–198.
Sobala GM, Schorah CJ, Sanderson M, Dixon MF, Tomkins DS, Godwin P & Axon ATR (1989) Ascorbic acid in the human stomach. Gastroenterology 97, 357–363.
Sobala GM, Schorah CJ, Shires S, Lynch DAF, Gallacher B, Dixon MF & Axon ATR (1993) Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 34, 1038–1041.
Stockbruegger RW (1985) Bacterial overgrowth as a consequence of reduced gastric acidity. Scandinavian Journal of Gastroenterology 111, Suppl., 7–16.
Stolte M, Meining A, Seifert E & Alexandridis T (2000) Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach. Pathology, Research and Practice 196, 9–13.
Thurnham DI, Smith E & Fiora PS (1988) Concurrent liquid chromatographic assay of retinal, α-tocopherol, β-carotene, α-carotene, lycopene and β-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clinical Chemistry 34, 377–381.
Waring AJ, Drake IM, Schorah CJ, White KLM, Lynch DAF, Axon ATR & Dixon MF (1996) Ascorbic acid and total vitamin C concentration in plasma, gastric juice and gastric intestinal mucosa; effects of gastritis and oral supplementation. Gut 38, 171–176.
Whitehead TP, Thorpe GHG & Maxwell SRJ (1992) Enhanced chemiluminescence assay for antioxidant capacity in biological fluids. Analytica Chimica Acta 266, 265–277.
Yagi K (1976) A simple fluorometric assay for lipoperoxide in blood plasma. Biochemical Medicine 15, 212–216.